Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

112.53
-2.2450-1.96%
Volume:435.65K
Turnover:48.95M
Market Cap:26.98B
PE:-51.98
High:113.24
Open:112.26
Low:111.30
Close:114.77
Loading ...

CVS Pharmacy® introduces enhanced flu testing and treatment offerings

PR Newswire
·
27 Feb

Deutsche Pfandbriefbank (0R9K) Receives a Buy from Warburg Research

TIPRANKS
·
27 Feb

Medibank Announces $160 Million Customer Give Back Amid COVID-19 Support

TIPRANKS
·
27 Feb

BioNTech SE (BNTX): Among the Best Vaccine Stocks to Buy According to Hedge Funds

Insider Monkey
·
26 Feb

IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19

GlobeNewswire
·
26 Feb

OraSure Reports Fourth Quarter 2024 Financial Results

GlobeNewswire
·
26 Feb

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Business Wire
·
24 Feb

Invivyd’s Strategic Positioning and Growth Potential in COVID-19 Prophylaxis Market: A Buy Rating Despite Regulatory Challenges

TIPRANKS
·
24 Feb

GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness

NewMediaWire
·
24 Feb

Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus

Zacks
·
24 Feb

Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX)

TIPRANKS
·
24 Feb

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Benzinga
·
24 Feb

Invivyd Shares Down as Regulators Decline Expanded Use for Covid-19 Treatment

Dow Jones
·
24 Feb

Invivyd's Request to Treat Covid-19 Patients With Pemgarda Rejected by US FDA

MT Newswires Live
·
24 Feb

FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing PEMGARDA EUA for Pre-Exposure Prophylaxis of COVID-19 in Certain Immunocompromised Patients

GlobeNewswire
·
24 Feb

BNTX Insider Trade Alert! Co-Founder and CEO Sells BioNTech Stock Worth $119M

TIPRANKS
·
24 Feb